Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

ClinicalTrials.gov ID: NCT01428661

Public ClinicalTrials.gov record NCT01428661. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MAGELLAN: A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Study to Investigate the Safety and Efficacy of 20 Mg Tasimelteon Versus Placebo in Adult Subjects With Major Depressive Disorder Followed by a 52-Week Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of an 8-week double-masked treatment of tasimelteon or placebo in male and female subjects with Major Depressive Disorder.

Study identification

NCT ID
NCT01428661
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
507 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2011 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
May 2013 (Actual)
Last update posted
Jun 19, 2015

2011 – 2013

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Vanda Investigational Site Garden Grove California 92845 —
Vanda Investigational Site Irvine California 92617 —
Vanda Investigational Site Los Alamitos California 90720 —
Vanda Investigational Site Oakland California 94612 —
Vanda Investigational Site Oceanside California 92056 —
Vanda Investigational Site San Diego California 92102 —
Vanda Investigational Site Sherman Oaks California 91403 —
Vanda Investigational Site Torrance California 90502 —
Vanda Investigational Site Denver Colorado 80239 —
Vanda Investigational Site Bradenton Florida 34201 —
Vanda Investigational Site Jacksonville Florida 32216 —
Vanda Investigational Site Maitland Florida 32751 —
Vanda Investigational Site North Miami Florida 33161 —
Vanda Investigational Site Orlando Florida 32806 —
Vanda Investigational Site Atlanta Georgia 30308 —
Vanda Investigational Site Atlanta Georgia 30328 —
Vanda Investigational Site Chicago Illinois 60640 —
Vanda Investigational Site Joliet Illinois 60435 —
Vanda Investigational Site Prairie Village Kansas 66205 —
Vanda Investigational Site Baltimore Maryland 21208 —
Vanda Investigational Site Boston Massachusetts 02135 —
Vanda Investigational Site Omaha Nebraska 68198 —
Vanda Investigational Site Las Vegas Nevada 89102 —
Vanda Investigational Site Toms River New Jersey 08755 —
Vanda Investigational Site Willingboro New Jersey 08046 —
Vanda Investigational Site Brooklyn New York 11235 —
Vanda Investigational Site Mount Kisco New York 10549 —
Vanda Investigational Site New York New York 10168 —
Vanda Investigational Site Rochester New York 14618 —
Vanda Investigational Site Staten Island New York 10312 —
Vanda Investigational Site Cincinnati Ohio 45267 —
Vanda Investigational Site Dayton Ohio 45417 —
Vanda Investigational Site Portland Oregon 97210 —
Vanda Investigational Site Lincoln Rhode Island 02865 —
Vanda Investigational Site Memphis Tennessee 38119 —
Vanda Investigational Site Austin Texas 78731 —
Vanda Investigational Site Dallas Texas 75231 —
Vanda Investigational Site Salt Lake City Utah 84106 —
Vanda Investigational Site Seattle Washington 98104 —
Vanda Investigational Site Brown Deer Wisconsin 53223 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01428661, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2015 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01428661 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →